Moncef Slaoui, head of Operation Warp Speed (AP Images)

Covid-19 roundup: No­vavax re­cruits As­traZeneca vet as its new CMO — right af­ter David Mott jumps on the board; Op­er­a­tion Warp Speed will cut to 7 can­di­dates

One of the dark-horse con­tenders in a race to the fin­ish line with a new vac­cine for Covid-19 has just wooed a se­nior As­traZeneca re­searcher to the fold as its new chief med­ical of­fi­cer.

No­vavax re­ports that it has re­cruit­ed Fil­ip Dubovsky to the team af­ter a 14-year stretch at Med­Im­mune/As­traZeneca. While at the big As­traZeneca sub, Dubovsky had been area head for in­fec­tious dis­eases and vac­cines. Ear­li­er he had been sci­en­tif­ic di­rec­tor for PATH, a malar­ia vac­cine ini­tia­tive.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.